NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-131-2020-7-RU-07 Anti-Coronavirus Antibodies And Methods Of Use RU ORD 2020141137 Issued
NIAID E-131-2020-7-TW-08 Anti-Coronavirus Antibodies And Methods Of Use TW ORD 109144053 Issued
NIAID E-131-2020-7-GB-12 Anti-Coronavirus Antibodies And Methods Of Use GB ORD 2019709.1 Pending
NIAID E-131-2020-7-HK-13 Anti-Coronavirus Antibodies And Methods Of Use HK EP 42021039063.9 Pending
NIAID E-131-2020-7-AR-03 Anti-Coronavirus Antibodies And Methods Of Use AR ORD P200103485 Pending
NIAID E-131-2020-7-PK-01 Anti-Coronavirus Antibodies And Methods Of Use PK ORD 855/2020 Pending
NIAID E-131-2020-7-LB-06 Anti-Coronavirus Antibodies And Methods Of Use LB ORD 12076 Pending
NIAID E-131-2020-7-EP-10 Anti-Coronavirus Antibodies And Methods Of Use EP ORD 20213900.2 Pending
NIAID E-131-2020-7-GC-04 Anti-Coronavirus Antibodies And Methods Of Use GC ORD 41303 Pending
NIAID E-153-2019-1-PCT-01 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE PCT PCT COMB PCT/US2020/064619 Expired
NCI E-003-2020-0-PCT-02 PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY PCT PCT PCT/US2020/064412 Expired
NCI E-003-2020-0-CN-04 PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY CN National Stage 202080086575.3 Pending
NIAID E-153-2019-1-CN-05 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE CN National Stage 202080096383.0 Pending
NIAID E-153-2019-1-EP-06 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE EP National Stage 20841798.0 Pending
NIAID E-153-2019-1-JP-09 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE JP National Stage 2022-535470 Pending
NIAID E-153-2019-1-NZ-11 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE NZ National Stage 789242 Pending
NCI E-003-2020-0-EP-05 PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY EP National Stage 20899103.4 Pending
NIAID E-153-2019-1-ZA-14 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE ZA National Stage 2022/06497 Pending
NIAID E-153-2019-1-SG-12 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE SG National Stage 11202250095U Pending
NCI E-003-2020-0-KR-07 PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY KR National Stage 10-2022-7023239 Pending
NIAID E-153-2019-1-KR-10 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE KR National Stage 10-2022-7023549 Pending
NCI E-003-2020-0-AU-03 PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY AU National Stage 2020403013 Pending
NIAID E-153-2019-1-AU-02 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE AU National Stage 2020402106 Pending
NIAID E-153-2019-1-BR-03 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE BR National Stage BR112022011422-2 Pending
NIAID E-153-2019-1-CA-04 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE CA National Stage 3164343 Pending
NIAID E-153-2019-1-IL-07 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE IL National Stage 293666 Pending
NIAID E-153-2019-1-IN-08 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE IN National Stage 202217038319 Pending
NCI E-040-2012-0-US-60 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 17/117,335 11377660 Issued PDF
NCI E-040-2012-0-US-61 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 17/117,368 11359204 Issued PDF
NCI E-040-2012-0-US-59 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 17/117,311 11066674 Issued PDF
NICHD E-026-2019-0-US-03 POLYPEPTIDES, NUCLEIC ACID MOLECULES, COMPOSITIONS, AND RELATED METHODS US National Stage 17/251,019 Pending
NIAID E-131-2020-7-PCT-01 Anti-Coronavirus Antibodies And Methods Of Use PCT PCT COMB PCT/US2020/063991 Expired
NIAID E-131-2020-7-CN-01 Anti-Coronavirus Antibodies And Methods Of Use CN National Stage 202080100619.3 Pending
NIAID E-131-2020-7-EG-17 Anti-Coronavirus Antibodies And Methods Of Use EG National Stage 1289/2022 Pending
NIAID E-131-2020-7-CA-16 Anti-Coronavirus Antibodies And Methods Of Use CA National Stage 3171237 Pending
NIAID E-131-2020-7-US-02 Anti-Coronavirus Antibodies And Methods Of Use US ORD 17/116,588 Abandoned
NIAID E-131-2020-7-ZA-19 Anti-Coronavirus Antibodies And Methods Of Use ZA National Stage 2022/10039 Pending
NCATS E-114-2018-0-EP-05 FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS EP National Stage 19728226.2 Pending
NIAID E-131-2020-7-JP-01 Anti-Coronavirus Antibodies And Methods Of Use JP National Stage 2022-554810 Pending
NIAID E-131-2020-7-MX-20 Anti-Coronavirus Antibodies And Methods Of Use MX National Stage MX/a/2022/011142 Pending
NIAID E-131-2020-7-AU-14 Anti-Coronavirus Antibodies And Methods Of Use AU National Stage 2020435452 Pending
NIAID E-131-2020-7-BR-15 Anti-Coronavirus Antibodies And Methods Of Use BR National Stage BR112022017986-3 Pending
NIAID E-131-2020-7-IL-18 Anti-Coronavirus Antibodies And Methods Of Use IL National Stage 296224 Pending
NHLBI E-025-2019-0-PCT-02 ANTIBODIES TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3D AND USE THEREOF PCT PCT PCT/US2020/063809 Expired
NCI E-145-2019-0-PCT-02 ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD276 AND USES THEREOF PCT PCT PCT/US2020/063732 Expired
NIAID E-145-2015-3-US-15 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV US CON 17/115,026 Pending
NCI E-145-2019-0-EP-05 ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD276 AND USES THEREOF EP National Stage 20834060.4 Pending
NCI E-229-2014-0-EP-09 Methods of Isolating T Cells Having Antigenic Specificity for a Cancer-Specific Mutation EP DIV 20212578.7 Pending
NCI E-145-2019-0-JP-06 ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD276 AND USES THEREOF JP National Stage 2022-535127 Pending
NIAID E-145-2011-0-US-17 PLASMODIAL SURFACE ANION CHANNEL INHIBITORS FOR THE TREATMENT OR PREVENTION OF MALARIA US DIV 17/115,317 Pending